ES514584A0 - Procedimiento para la obtencion de derivados de imidazol trisustituidos. - Google Patents
Procedimiento para la obtencion de derivados de imidazol trisustituidos.Info
- Publication number
- ES514584A0 ES514584A0 ES514584A ES514584A ES514584A0 ES 514584 A0 ES514584 A0 ES 514584A0 ES 514584 A ES514584 A ES 514584A ES 514584 A ES514584 A ES 514584A ES 514584 A0 ES514584 A0 ES 514584A0
- Authority
- ES
- Spain
- Prior art keywords
- trisustituted
- procedure
- obtaining
- imidazole derivatives
- imidazole
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/53—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/46—Oxygen atoms
- C07D213/50—Ketonic radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D233/26—Radicals substituted by carbon atoms having three bonds to hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Ophthalmology & Optometry (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH571580 | 1980-07-25 |
Publications (2)
Publication Number | Publication Date |
---|---|
ES8306124A1 ES8306124A1 (es) | 1983-05-16 |
ES514584A0 true ES514584A0 (es) | 1983-05-16 |
Family
ID=4298165
Family Applications (8)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES504257A Granted ES504257A0 (es) | 1980-07-25 | 1981-07-24 | Procedimiento para la obtencion de derivados de imidazol trisustituidos |
ES514582A Expired ES8306122A1 (es) | 1980-07-25 | 1982-07-30 | Procedimiento para la obtencion de derivados de imidazol trisustituidos. |
ES514583A Granted ES514583A0 (es) | 1980-07-25 | 1982-07-30 | Procedimiento para la obtencion de derivados de imidazol trisustituidos. |
ES514579A Granted ES514579A0 (es) | 1980-07-25 | 1982-07-30 | Procedimiento para la obtencion de derivados de imidazol trisustituidos. |
ES514580A Expired ES8306120A1 (es) | 1980-07-25 | 1982-07-30 | Procedimiento para la obtencion de derivados de imidazol trisustituidos. |
ES514584A Granted ES514584A0 (es) | 1980-07-25 | 1982-07-30 | Procedimiento para la obtencion de derivados de imidazol trisustituidos. |
ES514581A Granted ES514581A0 (es) | 1980-07-25 | 1982-07-30 | Procedimiento para la obtencion de derivados de imidazol trisustituidos. |
ES514585A Expired ES8307245A1 (es) | 1980-07-25 | 1982-07-30 | Procedimiento para la obtencion de derivados de oxazol trisustituidos. |
Family Applications Before (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES504257A Granted ES504257A0 (es) | 1980-07-25 | 1981-07-24 | Procedimiento para la obtencion de derivados de imidazol trisustituidos |
ES514582A Expired ES8306122A1 (es) | 1980-07-25 | 1982-07-30 | Procedimiento para la obtencion de derivados de imidazol trisustituidos. |
ES514583A Granted ES514583A0 (es) | 1980-07-25 | 1982-07-30 | Procedimiento para la obtencion de derivados de imidazol trisustituidos. |
ES514579A Granted ES514579A0 (es) | 1980-07-25 | 1982-07-30 | Procedimiento para la obtencion de derivados de imidazol trisustituidos. |
ES514580A Expired ES8306120A1 (es) | 1980-07-25 | 1982-07-30 | Procedimiento para la obtencion de derivados de imidazol trisustituidos. |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES514581A Granted ES514581A0 (es) | 1980-07-25 | 1982-07-30 | Procedimiento para la obtencion de derivados de imidazol trisustituidos. |
ES514585A Expired ES8307245A1 (es) | 1980-07-25 | 1982-07-30 | Procedimiento para la obtencion de derivados de oxazol trisustituidos. |
Country Status (23)
Country | Link |
---|---|
US (1) | US4447431A (es) |
EP (1) | EP0045081B1 (es) |
JP (1) | JPS5756466A (es) |
KR (13) | KR850000883B1 (es) |
AR (1) | AR230269A1 (es) |
AT (1) | ATE17349T1 (es) |
AU (2) | AU7340481A (es) |
CA (1) | CA1175431A (es) |
DD (2) | DD201677A5 (es) |
DE (1) | DE3173434D1 (es) |
DK (1) | DK331881A (es) |
ES (8) | ES504257A0 (es) |
FI (1) | FI812326L (es) |
GB (1) | GB2080805B (es) |
GR (1) | GR75287B (es) |
IE (1) | IE52071B1 (es) |
IL (1) | IL63410A (es) |
NO (1) | NO812542L (es) |
NZ (1) | NZ197828A (es) |
PL (8) | PL236997A1 (es) |
PT (1) | PT73424B (es) |
SU (8) | SU1235454A3 (es) |
ZA (1) | ZA815078B (es) |
Families Citing this family (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2123831B (en) * | 1981-07-20 | 1986-01-15 | Ciba Geigy Ag | Trisubstituted oxazo compounds |
EP0084756A1 (de) * | 1982-01-22 | 1983-08-03 | Ciba-Geigy Ag | Trisubstituierte Oxazaverbindungen |
FR2633291B1 (fr) * | 1988-06-27 | 1990-09-07 | Oreal | Derives d'hydroxy-4 isoxazoles, leur procede de preparation et compositions cosmetiques et pharmaceutiques les contenant |
US5252322A (en) * | 1989-09-22 | 1993-10-12 | The Gillette Company | Skin tanning compositions containing imidazoles |
NZ239161A (en) * | 1990-07-31 | 1994-01-26 | Smithkline Beecham Corp | Substituted [1h-imidazol-5-yl] alkanoic acid derivatives; medicaments, |
US5916891A (en) | 1992-01-13 | 1999-06-29 | Smithkline Beecham Corporation | Pyrimidinyl imidazoles |
IL104369A0 (en) * | 1992-01-13 | 1993-05-13 | Smithkline Beecham Corp | Novel compounds and compositions |
US5670527A (en) * | 1993-07-16 | 1997-09-23 | Smithkline Beecham Corporation | Pyridyl imidazole compounds and compositions |
US5593991A (en) * | 1993-07-16 | 1997-01-14 | Adams; Jerry L. | Imidazole compounds, use and process of making |
US5593992A (en) * | 1993-07-16 | 1997-01-14 | Smithkline Beecham Corporation | Compounds |
EP1306377A3 (en) * | 1993-11-08 | 2003-05-07 | Smithkline Beecham Corporation | Pyridyl-oxazoles and their use as cytokines inhibitors |
US5723477A (en) * | 1994-11-10 | 1998-03-03 | Sibia Neurosciences, Inc. | Modulators of acetylcholine receptors |
US5658903A (en) * | 1995-06-07 | 1997-08-19 | Smithkline Beecham Corporation | Imidazole compounds, compositions and use |
US5739143A (en) * | 1995-06-07 | 1998-04-14 | Smithkline Beecham Corporation | Imidazole compounds and compositions |
US6369068B1 (en) | 1995-06-07 | 2002-04-09 | Smithkline Beecham Corporation | Amino substituted pyrimidine containing compounds |
ZA9610687B (en) | 1995-12-22 | 1997-09-29 | Smithkline Beecham Corp | Novel synthesis. |
US6046208A (en) * | 1996-01-11 | 2000-04-04 | Smithkline Beecham Corporation | Substituted imidazole compounds |
AP9700912A0 (en) | 1996-01-11 | 1997-01-31 | Smithkline Beecham Corp | Novel cycloalkyl substituted imidazoles |
NZ327044A (en) * | 1996-01-11 | 2000-01-28 | Smithkline Beecham Corp | Substituted imidazole compounds |
ZA97175B (en) * | 1996-01-11 | 1997-11-04 | Smithkline Beecham Corp | Novel substituted imidazole compounds. |
JP2000507558A (ja) * | 1996-03-25 | 2000-06-20 | スミスクライン・ビーチャム・コーポレイション | Cns損傷についての新規な治療 |
WO1998007425A1 (en) | 1996-08-21 | 1998-02-26 | Smithkline Beecham Corporation | Imidazole compounds, compositions and use |
US5929076A (en) * | 1997-01-10 | 1999-07-27 | Smithkline Beecham Corporation | Cycloalkyl substituted imidazoles |
UA65572C2 (en) * | 1997-04-24 | 2004-04-15 | Ortho Mcneil Pharm Inc | Substituted imidazoles, intermediate compounds for the preparation thereof, a method for the preparation of substituted imidazoles and a method for the treatment of inflammatory diseases |
JP2002504909A (ja) | 1997-06-13 | 2002-02-12 | スミスクライン・ビーチャム・コーポレイション | 新規な置換ピラゾールおよびピラゾリン化合物 |
EP0994870A4 (en) | 1997-06-19 | 2002-10-23 | Smithkline Beecham | NEW IMIDAZOLE COMPOUNDS SUBSTITUTED BY AN ARYLOXYREST |
US6489325B1 (en) | 1998-07-01 | 2002-12-03 | Smithkline Beecham Corporation | Substituted imidazole compounds |
TW517055B (en) | 1997-07-02 | 2003-01-11 | Smithkline Beecham Corp | Novel substituted imidazole compounds |
AR016294A1 (es) * | 1997-07-02 | 2001-07-04 | Smithkline Beecham Corp | Compuesto de imidazol sustituido, composicion farmaceutica que la contiene, su uso en la fabricacion de un medicamento y procedimiento para supreparacion |
US6562832B1 (en) | 1997-07-02 | 2003-05-13 | Smithkline Beecham Corporation | Substituted imidazole compounds |
US7301021B2 (en) * | 1997-07-02 | 2007-11-27 | Smithkline Beecham Corporation | Substituted imidazole compounds |
WO1999001452A1 (en) | 1997-07-02 | 1999-01-14 | Smithkline Beecham Corporation | Novel cycloalkyl substituted imidazoles |
US6362193B1 (en) | 1997-10-08 | 2002-03-26 | Smithkline Beecham Corporation | Cycloalkenyl substituted compounds |
WO1999032121A1 (en) | 1997-12-19 | 1999-07-01 | Smithkline Beecham Corporation | Compounds of heteroaryl substituted imidazole, their pharmaceutical compositions and uses |
TR200003472T2 (tr) * | 1998-05-22 | 2001-09-21 | Smithkline Beecham Corporation | Yeni 2-alkil ikameli imidazol bileşikler |
US6858617B2 (en) | 1998-05-26 | 2005-02-22 | Smithkline Beecham Corporation | Substituted imidazole compounds |
EP1112070B1 (en) * | 1998-08-20 | 2004-05-12 | Smithkline Beecham Corporation | Novel substituted triazole compounds |
AU1909200A (en) * | 1998-11-04 | 2000-05-22 | Smithkline Beecham Corporation | Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines |
WO2000029399A1 (en) * | 1998-11-12 | 2000-05-25 | Boehringer Ingelheim (Canada) Ltd. | Antiherpes compounds |
US6239279B1 (en) | 1998-12-16 | 2001-05-29 | Smithkline Beecham Corporation | Synthesis for 4-aryl-5-pyrimidine imidazole substituted derivatives |
AU1623601A (en) | 1999-11-22 | 2001-06-04 | Smithkline Beecham Plc | Novel compounds |
US6759410B1 (en) * | 1999-11-23 | 2004-07-06 | Smithline Beecham Corporation | 3,4-dihydro-(1H)-quinazolin-2-ones and their use as CSBP/p38 kinase inhibitors |
DE60020595T2 (de) | 1999-11-23 | 2006-03-16 | Smithkline Beecham Corp. | 3,4-dihydro-(1h)chinazolin-2-on-verbindungen als csbp/p38-kinase-inhibitoren |
ATE305787T1 (de) | 1999-11-23 | 2005-10-15 | Smithkline Beecham Corp | 3,4-dihydro-(1h)chinazolin-2-on-verbindungen als csbp/p39-kinase-inhibitoren |
AU1781601A (en) | 1999-11-23 | 2001-06-04 | Smithkline Beecham Corporation | 3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p38 kinase inhibitors |
US7235551B2 (en) * | 2000-03-02 | 2007-06-26 | Smithkline Beecham Corporation | 1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases |
ES2218391T3 (es) * | 2000-03-06 | 2004-11-16 | Smithkline Beecham Plc | Derivados de imidazol como inhibidores de raf-cinasa. |
GB0005357D0 (en) | 2000-03-06 | 2000-04-26 | Smithkline Beecham Plc | Compounds |
CZ20031125A3 (cs) * | 2000-10-23 | 2003-10-15 | Smithkline Beecham Corporation | Nové sloučeniny |
GB0112348D0 (en) * | 2001-05-19 | 2001-07-11 | Smithkline Beecham Plc | Compounds |
WO2003022837A1 (en) * | 2001-09-05 | 2003-03-20 | Smithkline Beecham P.L.C. | Heterocycle-carboxamide derivatives as raf kinase inhibitors |
TW200505446A (en) * | 2003-01-17 | 2005-02-16 | Fuj Isawa Pharmaceutical Co Ltd | Inhibitor of cox |
JP2006525320A (ja) * | 2003-05-08 | 2006-11-09 | アステラス製薬株式会社 | Cox阻害剤 |
US7479558B2 (en) * | 2005-03-25 | 2009-01-20 | Glaxo Group Limited | Process for preparing pyrido[2,3-d]pyrimidin-7-one and 3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one derivatives |
PE20100737A1 (es) | 2005-03-25 | 2010-11-27 | Glaxo Group Ltd | Nuevos compuestos |
WO2013049272A2 (en) | 2011-09-29 | 2013-04-04 | Theraceutix, Llc | Composition and method for treatment of symptoms associated with various skin conditions |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3558645A (en) * | 1968-07-08 | 1971-01-26 | Sandoz Ag | 2-(4-(4',5-diphenyl - 2 - imidazolyl)-phenoxy) lower aliphatic monocarboxylic acids |
CH561202A5 (es) * | 1971-05-10 | 1975-04-30 | Ciba Geigy Ag | |
GB1469532A (en) * | 1973-06-28 | 1977-04-06 | Dumex Ltd As | Imimdazolyl-alkanoic acid derivatives |
US4372964A (en) * | 1980-10-30 | 1983-02-08 | E. I. Du Pont De Nemours And Company | Antiinflammatory 4,5-diaryl-1H-imidazole-2-methanols |
-
1981
- 1981-07-23 GR GR65613A patent/GR75287B/el unknown
- 1981-07-23 DD DD81232030A patent/DD201677A5/de unknown
- 1981-07-23 CA CA000382377A patent/CA1175431A/en not_active Expired
- 1981-07-24 DK DK331881A patent/DK331881A/da not_active Application Discontinuation
- 1981-07-24 SU SU813317053A patent/SU1235454A3/ru active
- 1981-07-24 GB GB8122920A patent/GB2080805B/en not_active Expired
- 1981-07-24 NO NO812542A patent/NO812542L/no unknown
- 1981-07-24 AU AU73404/81A patent/AU7340481A/en not_active Abandoned
- 1981-07-24 ES ES504257A patent/ES504257A0/es active Granted
- 1981-07-24 ZA ZA815078A patent/ZA815078B/xx unknown
- 1981-07-24 IE IE1680/81A patent/IE52071B1/en unknown
- 1981-07-24 PT PT73424A patent/PT73424B/pt unknown
- 1981-07-24 IL IL63410A patent/IL63410A/xx unknown
- 1981-07-24 FI FI812326A patent/FI812326L/fi not_active Application Discontinuation
- 1981-07-24 NZ NZ197828A patent/NZ197828A/en unknown
- 1981-07-25 KR KR1019810002709A patent/KR850000883B1/ko active
- 1981-07-25 PL PL23699781A patent/PL236997A1/xx unknown
- 1981-07-25 PL PL23700481A patent/PL237004A1/xx unknown
- 1981-07-25 PL PL23700381A patent/PL237003A1/xx unknown
- 1981-07-25 PL PL23700281A patent/PL237002A1/xx unknown
- 1981-07-25 JP JP56115896A patent/JPS5756466A/ja active Pending
- 1981-07-25 PL PL23700081A patent/PL237000A1/xx unknown
- 1981-07-25 PL PL1981232352A patent/PL135822B1/pl unknown
- 1981-07-25 PL PL23700581A patent/PL237005A1/xx unknown
- 1981-07-25 PL PL23700181A patent/PL237001A1/xx unknown
- 1981-07-27 AT AT81105914T patent/ATE17349T1/de not_active IP Right Cessation
- 1981-07-27 DE DE8181105914T patent/DE3173434D1/de not_active Expired
- 1981-07-27 EP EP81105914A patent/EP0045081B1/de not_active Expired
-
1982
- 1982-07-21 SU SU823465351A patent/SU1138023A3/ru active
- 1982-07-21 SU SU823466066A patent/SU1145928A3/ru active
- 1982-07-21 SU SU823465356A patent/SU1205764A3/ru active
- 1982-07-21 SU SU823466067A patent/SU1227112A3/ru active
- 1982-07-30 ES ES514582A patent/ES8306122A1/es not_active Expired
- 1982-07-30 ES ES514583A patent/ES514583A0/es active Granted
- 1982-07-30 ES ES514579A patent/ES514579A0/es active Granted
- 1982-07-30 SU SU823469534A patent/SU1152520A3/ru active
- 1982-07-30 ES ES514580A patent/ES8306120A1/es not_active Expired
- 1982-07-30 DD DD82242110A patent/DD202554A5/de unknown
- 1982-07-30 ES ES514584A patent/ES514584A0/es active Granted
- 1982-07-30 ES ES514581A patent/ES514581A0/es active Granted
- 1982-07-30 ES ES514585A patent/ES8307245A1/es not_active Expired
- 1982-07-30 SU SU823468675A patent/SU1169534A3/ru active
- 1982-09-28 US US06/425,603 patent/US4447431A/en not_active Expired - Fee Related
- 1982-11-22 AR AR291374A patent/AR230269A1/es active
-
1983
- 1983-07-19 SU SU833618708A patent/SU1205763A3/ru active
-
1984
- 1984-09-27 KR KR1019840005964A patent/KR850000887B1/ko active IP Right Grant
- 1984-09-27 KR KR1019840005963A patent/KR850000886B1/ko active IP Right Grant
- 1984-09-27 KR KR1019840005966A patent/KR850000889B1/ko active IP Right Grant
- 1984-09-27 KR KR1019840005971A patent/KR850000892B1/ko active IP Right Grant
- 1984-09-27 KR KR1019840005972A patent/KR850001064B1/ko active IP Right Grant
- 1984-09-27 KR KR1019840005968A patent/KR850000890B1/ko active IP Right Grant
- 1984-09-27 KR KR1019840005970A patent/KR850000911B1/ko active IP Right Grant
- 1984-09-27 KR KR1019840005969A patent/KR850000891B1/ko active IP Right Grant
- 1984-09-27 KR KR1019840005960A patent/KR850000873B1/ko active IP Right Grant
- 1984-09-27 KR KR1019840005965A patent/KR850000888B1/ko active IP Right Grant
- 1984-09-27 KR KR1019840005962A patent/KR850000885B1/ko active IP Right Grant
- 1984-09-27 KR KR1019840005961A patent/KR850000884B1/ko active IP Right Grant
-
1986
- 1986-04-23 AU AU56555/86A patent/AU5655586A/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES514584A0 (es) | Procedimiento para la obtencion de derivados de imidazol trisustituidos. | |
ES523709A0 (es) | Procedimiento para la preparacion de derivados de imidazol. | |
AR223315A1 (es) | Procedimiento para la fabricacion de derivados de 2-guanidin-(tiazol o imidazol) | |
ES513228A0 (es) | Un procedimiento para la preparacion de una composicion de derivados del imidazol. | |
ES504791A0 (es) | Procedimiento para la preparacion de derivados de caprolactama. | |
ES528181A0 (es) | Procedimiento para la obtencion de derivados de imidazol (i,5-a)-piridina | |
ES498208A0 (es) | Procedimiento para la obtencion de derivados de triazolilfe-nacil-piridil-eter, de efecto fungicida | |
ES515031A0 (es) | Procedimiento para la obtencion de derivados de azolil-fenoxisustituidos. | |
ES510875A0 (es) | Un procedimiento para la preparacion de un derivado del imidazol. | |
ES518274A0 (es) | Procedimiento para la preparacion de derivados de tiazolina. | |
ES511317A0 (es) | Procedimiento para preparar derivados de imidazol. | |
ES513392A0 (es) | Procedimiento para la obtencion de derivados de 2-amino-piridina sustituidos. | |
ES537959A0 (es) | Procedimiento para preparar derivados de imidazol. | |
ES498364A0 (es) | Un procedimiento para la preparacion de derivados del imidazol. | |
ES513169A0 (es) | Procedimiento para la obtencion de nuevos derivados de benzazol. | |
ES514479A0 (es) | Procedimiento para la obtencion de derivados de diaril-imidazol. | |
ES502162A0 (es) | Procedimiento para la obtencion de derivados del imidazol. | |
ES530042A0 (es) | Procedimiento para la obtencion de derivados de imidazol conteniendo azufre | |
ES506911A0 (es) | Procedimiento para la obtencion de derivados pirazolicos de la oximinociano-acetamida de efecto fungicida. | |
ES539306A0 (es) | Procedimiento para preparar derivados de imidazol con actividad antitrombotica. | |
ES501700A0 (es) | Procedimiento para la preparacion de derivados de imidazol | |
ES522859A0 (es) | Procedimiento para la obtencion de derivados de trifluormetilfenoxi-fenilo. | |
MX6968E (es) | Procedimiento para preparar salicilato de imidazol | |
ES523287A0 (es) | Procedimiento para la obtencion de hidantoinas n-sulfeniladas. | |
ES519843A0 (es) | Procedimiento para la obtencion de derivados de tetrahicro-2 pirimidona metil-sustituidos. |